BAROPHARM Co., Ltd. (KOSDAQ:0153R0)
6,700.00
-610.00 (-8.34%)
At close: Nov 17, 2026
BAROPHARM Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Net Income | 1,504 | -9,679 | -17,522 | -7,107 |
Depreciation & Amortization | 915.89 | 843.38 | 652.96 | 373.05 |
Loss (Gain) From Sale of Assets | -13.11 | -21.91 | 1.55 | - |
Stock-Based Compensation | 804.96 | 934.27 | 1,173 | 1,185 |
Other Operating Activities | 1,401 | 5,955 | 12,347 | 4,760 |
Change in Accounts Receivable | 2,094 | -1,837 | -5,827 | -361.43 |
Change in Inventory | -5,139 | -6,488 | -10,967 | -862.89 |
Change in Accounts Payable | 6,722 | -322.29 | 11,597 | -1,367 |
Change in Unearned Revenue | 22.91 | 12.41 | - | - |
Change in Income Taxes | 0.14 | - | - | -30.62 |
Change in Other Net Operating Assets | -6,917 | 4,051 | 6,092 | -2,400 |
Operating Cash Flow | 1,395 | -6,552 | -2,453 | -5,810 |
Operating Cash Flow Growth | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Capital Expenditures | -20,587 | -19,575 | -106.4 | -92.1 |
Sale of Property, Plant & Equipment | 40.32 | 82.05 | 16.14 | - |
Cash Acquisitions | - | -1,187 | - | -4.03 |
Investment in Securities | 1,037 | 11,988 | -11,919 | -8,916 |
Other Investing Activities | - | - | 0 | -0 |
Investing Cash Flow | -19,782 | -8,692 | -12,009 | -9,012 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Short-Term Debt Issued | - | 14,500 | - | 349 |
Total Debt Issued | 14,758 | 14,500 | - | 349 |
Short-Term Debt Repaid | - | - | - | -3,595 |
Long-Term Debt Repaid | - | -557.09 | -411.13 | -242.25 |
Total Debt Repaid | -1,103 | -557.09 | -411.13 | -3,837 |
Net Debt Issued (Repaid) | 13,655 | 13,943 | -411.13 | -3,488 |
Issuance of Common Stock | 505.04 | 1,508 | 3,000 | - |
Other Financing Activities | -0 | -1.87 | -24.69 | -0 |
Financing Cash Flow | 14,160 | 15,449 | 17,564 | 11,508 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Miscellaneous Cash Flow Adjustments | -0 | -0 | -0 | 0 |
Net Cash Flow | -4,227 | 205.16 | 3,101 | -3,315 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Free Cash Flow | -19,193 | -26,127 | -2,560 | -5,902 |
Free Cash Flow Growth | - | - | - | - |
Free Cash Flow Margin | -13.23% | -27.01% | -5.62% | -50.92% |
Free Cash Flow Per Share | -2035.36 | -3944.59 | -409.69 | -947.69 |
Levered Free Cash Flow | - | -68,759 | 20,563 | - |
Unlevered Free Cash Flow | - | -68,713 | 20,600 | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Cash Interest Paid | 501.07 | 94.75 | 58.78 | 93.11 |
Cash Income Tax Paid | - | 238.45 | 30.29 | - |
Change in Working Capital | -3,217 | -4,584 | 895.05 | -5,022 |